45.35
price down icon1.02%   -0.82
 
loading
Precedente Chiudi:
$46.17
Aprire:
$45.7
Volume 24 ore:
92,686
Relative Volume:
0.21
Capitalizzazione di mercato:
$1.46B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-12.36
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
+8.38%
1M Prestazione:
-13.43%
6M Prestazione:
-0.67%
1 anno Prestazione:
+72.32%
Intervallo 1D:
Value
$45.19
$46.27
Intervallo di 1 settimana:
Value
$41.50
$47.58
Portata 52W:
Value
$25.64
$68.73

Disc Medicine Inc Stock (IRON) Company Profile

Name
Nome
Disc Medicine Inc
Name
Telefono
(617) 674-9274
Name
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Name
Dipendente
84
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
IRON's Discussions on Twitter

Confronta IRON con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IRON
Disc Medicine Inc
45.41 1.46B 0 -91.00M -74.38M -3.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
491.85 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
598.08 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
611.89 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.67 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
246.60 24.89B 3.81B -644.79M -669.77M -6.24

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-27 Iniziato TD Cowen Buy
2024-11-05 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2024-11-04 Aggiornamento Raymond James Outperform → Strong Buy
2024-10-23 Iniziato Jefferies Buy
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-08-22 Iniziato Wells Fargo Overweight
2024-04-01 Downgrade Raymond James Strong Buy → Outperform
2023-12-19 Downgrade Morgan Stanley Overweight → Equal-Weight
2023-06-09 Aggiornamento Raymond James Outperform → Strong Buy
2023-06-07 Iniziato H.C. Wainwright Buy
2023-05-17 Iniziato Raymond James Outperform
2023-04-28 Iniziato Cantor Fitzgerald Overweight
2023-04-21 Iniziato Stifel Buy
2023-04-20 Iniziato Morgan Stanley Overweight
2023-03-23 Iniziato BMO Capital Markets Outperform
2023-02-28 Iniziato SVB Securities Outperform
Mostra tutto

Disc Medicine Inc Borsa (IRON) Ultime notizie

pulisher
Apr 21, 2025

JPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 21, 2025
pulisher
Apr 21, 2025

Renaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 21, 2025
pulisher
Apr 17, 2025

When (IRON) Moves Investors should Listen - news.stocktradersdaily.com

Apr 17, 2025
pulisher
Apr 17, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Geode Capital Management LLC - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

New GlyT-1 inhibitors disclosed in Disc Medicine patent - BioWorld MedTech

Apr 15, 2025
pulisher
Apr 14, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Brokerages - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald - MSN

Apr 13, 2025
pulisher
Apr 11, 2025

Vanguard Group Inc. Has $67.73 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 11, 2025
pulisher
Apr 09, 2025

Disc Medicine: Forging Ahead In Hematology (NASDAQ:IRON) - Seeking Alpha

Apr 09, 2025
pulisher
Apr 08, 2025

3,700 Shares in Disc Medicine, Inc. (NASDAQ:IRON) Acquired by KLP Kapitalforvaltning AS - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

Corebridge Financial Inc. Has $622,000 Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 08, 2025
pulisher
Apr 06, 2025

Disc Medicine, Inc.'s (NASDAQ:IRON) institutional investors lost 21% over the past week but have profited from longer-term gains - simplywall.st

Apr 06, 2025
pulisher
Apr 02, 2025

Teacher Retirement System of Texas Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Disc Medicine is Now Oversold (IRON) - Nasdaq

Apr 01, 2025
pulisher
Mar 29, 2025

Swiss National Bank Sells 2,600 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Mar 29, 2025
pulisher
Mar 27, 2025

Disc medicine director Ashiya Mona sells shares worth $310,483 By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

Orbimed advisors sells $310,483 in disc medicine stock By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 26, 2025

Is Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey

Mar 26, 2025
pulisher
Mar 26, 2025

Orbimed advisors sells $310,483 in disc medicine stock - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Disc medicine director Ashiya Mona sells shares worth $310,483 - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

10 Best Small-Cap Stocks to Buy Before They Explode - Insider Monkey

Mar 26, 2025
pulisher
Mar 25, 2025

Raymond James Financial Inc. Purchases New Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Mar 25, 2025
pulisher
Mar 23, 2025

With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing - Yahoo

Mar 23, 2025
pulisher
Mar 23, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Ashiya Mona sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com South Africa

Mar 22, 2025
pulisher
Mar 22, 2025

OrbiMed Advisors sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com Philippines

Mar 22, 2025
pulisher
Mar 22, 2025

Orbimed Advisors LLC Reduces Stake in Disc Medicine Inc: Analyzi - GuruFocus

Mar 22, 2025
pulisher
Mar 21, 2025

Ashiya Mona sells $2.83 million in Disc Medicine stock - Investing.com

Mar 21, 2025
pulisher
Mar 21, 2025

OrbiMed Advisors sells $2.83 million in Disc Medicine stock - Investing.com

Mar 21, 2025
pulisher
Mar 21, 2025

ORBIMED ADVISORS LLC Reduces Stake in Disc Medicine Inc - GuruFocus

Mar 21, 2025
pulisher
Mar 21, 2025

(IRON) Trading Advice - news.stocktradersdaily.com

Mar 21, 2025
pulisher
Mar 20, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Bank of New York Mellon Corp Buys 4,356 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Disc Medicine (NASDAQ:IRON) Given New $132.00 Price Target at Cantor Fitzgerald - Defense World

Mar 19, 2025
pulisher
Mar 16, 2025

Arizona State Retirement System Has $300,000 Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

Disc Medicine (IRON) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Disc medicine director Ashiya Mona sells $16.97 million in stock By Investing.com - Investing.com South Africa

Mar 12, 2025

Disc Medicine Inc Azioni (IRON) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Disc Medicine Inc Azioni (IRON) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Ashiya Mona
Director
Mar 24 '25
Sale
54.11
5,738
310,483
186,541
ORBIMED ADVISORS LLC
Director
Mar 24 '25
Sale
54.11
5,738
310,483
186,541
Ashiya Mona
Director
Mar 19 '25
Sale
54.02
39,656
2,142,217
188,981
Ashiya Mona
Director
Mar 21 '25
Sale
54.00
10,011
540,594
187,297
Ashiya Mona
Director
Mar 20 '25
Sale
54.01
2,762
149,176
188,617
ORBIMED ADVISORS LLC
Director
Mar 19 '25
Sale
54.02
39,656
2,142,217
188,981
ORBIMED ADVISORS LLC
Director
Mar 21 '25
Sale
54.00
10,011
540,594
187,297
ORBIMED ADVISORS LLC
Director
Mar 20 '25
Sale
54.01
2,762
149,176
188,617
Ashiya Mona
Director
Mar 10 '25
Sale
54.29
202,146
10,974,794
208,742
Ashiya Mona
Director
Mar 12 '25
Sale
54.45
83,182
4,529,507
194,209
$20.39
price down icon 0.63%
$68.60
price down icon 0.25%
$32.01
price down icon 0.09%
$34.64
price down icon 7.28%
$114.80
price down icon 4.57%
biotechnology ONC
$248.25
price down icon 2.59%
Capitalizzazione:     |  Volume (24 ore):